Promise for Crohn’s Sufferers as Vagus Nerve Stimulation Device Implanted in First Patient

Image credit: Bionics Institute

A Melbourne father has become the first patient to receive an implantable electrical stimulation device as part of an innovative potential treatment for Crohn’s disease.

The Australian-designed, world-first innovation gives fresh hope to the estimated 100,000 Australians who live with Crohn’s disease or ulcerative colitis and still face limited treatment options.

The size of a thumbnail, the tiny device is attached to the vagus nerve within the abdomen to help activate the body’s anti-inflammatory response, and prevent further damage to the gut after surgery.

The research is led by Professor James Fallon, Chief Technology Officer and Head of Research at the Bionics Institute in Melbourne.

“The vagus nerve controls many functions in the body, such as digestion, heart rate and the immune system,” explained Professor Fallon

“Our device is made up of tiny electrodes that stimulate the vagus nerve to trigger the body’s natural defences and prevent inflammation from damaging the gut – with the hope of allowing patients to continue their lives without the fear of further surgery.”

With Australia having one of the highest rates of inflammatory bowel disease in the world, the breakthrough will be exciting for many.

Check out the below story from 7News on this exciting technology, or learn more via the Bionics Institute.